Abstract Thin basement membrane nephropathy (TBMN) with heterozygous COL4A3/COL4A4 mutations is considered to be a cause of benign familial hematuria. The disease has been believed to have excellent prognosis and TBMN in early childhood is rarely associated with nephrotic-range proteinuria. Furthermore, the presence of proteinuria in patients with TBMN is associated with autosomal-dominant Alport syndrome, which has poorer prognosis in later life. We present an infant case of nephrotic-range proteinuria associated with TBMN caused by heterozygous COL4A4 mutation. A previously healthy 3-year-old boy developed microhematuria and nephroticrange proteinuria. Renal pathology simply revealed thinning of the glomerular basement membrane (GBM) and mutational analysis revealed a novel heterozygous mutation in COL4A4. He was treated with lisinopril for 1.5 years, which resolved his proteinuria and hematuria. At the most recent follow-up at 6.5 years of age, urinalysis and kidney function were completely normal, without requiring medication. However, transient but repeated moderate to nephrotic-range proteinuria and microscopic hematuria occurred in association with other illnesses. This case highlights the spectrum of phenotypes that may be apparent in an infant with TBMN. Thinning of the GBM can cause transient nephrotic-range proteinuria, particularly in the early stages of TBMN.
Background
Thin basement membrane nephropathy (TBMN) is a phenotypic variant of autosomal-dominant collagen type IV nephropathy, which is caused by heterozygous mutations of the type IV collagen genes, COL4A3 and COL4A4. TBMN with heterozygous COL4A3/COL4A4 mutations is considered to be a cause of benign familial hematuria and TBMN in early childhood is rarely associated with nephrotic-range proteinuria. Here, we report a 3-year-old boy with TBMN with a heterozygous COL4A4 mutation who experienced transient but repeated varying degrees of proteinuria.
Case report
A previously healthy 3-year-old boy with no family history of renal disease was referred to our hospital because of hematuria and proteinuria at his 3-year checkup. He had no clinical symptoms, and all of his vital signs and physical examinations were normal. His urinary protein/creatinine ratio (u-P/Cr) was 3.2 g/gCr and microhematuria was detected at the initial visit. His blood urea nitrogen, serum creatinine, and serum albumin levels were 12, 0.26, and 2.9 g/dL, respectively. Serum complement levels and renal ultrasound findings were normal. A renal biopsy was performed 30 days after detecting the urinary abnormality, because nephrotic-range proteinuria persisted. The glomeruli were almost normal under a light microscope, except for some proliferation of mesangial cells. Immunohistochemical analyses, including type IV collagen a5, were completely normal. The width of the glomerular basement membrane (GBM) was 150 nm under an electron microscope, which indicated global thinning of the GBM [1] . There was no evidence of basket-weave or split lesions (Fig. 1) . Foot process fusion was partly apparent, but these areas covered a mere 30 % of the visible range and it was not compatible with primary minimal change nephrotic syndrome. The direct sequencing of COL4A4 with genomic DNA from peripheral blood lymphocytes revealed that the patient and his mother had a heterozygous mutation of c. 827G [ C (p. G276A) in exon 14, but his father did not (Fig. 2) . We confirmed that a hundred healthy controls did not have the same mutation and that this is a diseasecausing mutation. Based on these results, we diagnosed the patient with TBMN with a heterozygous COL4A4 mutation. Therefore, treatment with an angiotensin-converting enzyme inhibitor (lisinopril 0.4 mg/kg/day) was started. His urinary abnormality and serum albumin level gradually improved, and lisinopril was discontinued 1.5 years after starting treatment. In 3.5 years after the initial presentation, i.e., at 6.5 years of age, his urinalysis and kidney function were normal, without requiring medication. However, the patient did develop transient episodes of moderate to nephrotic-range proteinuria and microscopic hematuria that lasted for approximately 1 month per episode. These events occurred in association with other illnesses, including pharyngitis and acute gastroenteritis. Discussion It is quite rare for infants with TBMN, such as this case, to develop nephrotic-range proteinuria. Pierides et al. [2] reported that TBMN associated with heterozygous COL4A3/COL4A4 mutations only resulted in microscopic hematuria or urinalysis that was negative in patients aged \30 years. In patients with Alport syndrome, a severe form of collagen type IV nephropathy, the initial renal manifestation is asymptomatic persistent microscopic hematuria, similar to that in TBMN. Proteinuria gradually develops over time in Alport syndrome after the development of longitudinal splits and lamellations of the GBM lamina densa. However, in our case, interestingly, we found no changes in the GBM other than diffuse thinning. Other researchers have reported that adults with TBMN may have moderate to nephrotic-range proteinuria of unknown etiology, with no changes in the GBM other than thinning [3, 4] . Our case showed that thinning of the GBM itself is associated with nephrotic-range proteinuria, even in the early stages of TBMN.
Type IV collagen, a component of GBM, is constructed of three a chains to form a triple helical molecule, and mutations in COL4A4 produce a posttranslational defect that prevents the correct structure of the collagen type IV network. Our patient has a mutation in the collagenous domain of COL4A4, which probably interferes with the proper formation and structure of the collagen triple helix. Type IV collagen nephropathy is clinically heterogenous [5] , and it seems probable enough that our patient revealed nephrotic-range proteinuria as a consequence of thinning of the GBM associated with COL4A4 mutation. 2:194-196 195 Our case is of special interest in that varying degrees of proteinuria developed transiently and repeatedly. The patient's mother had negative urine findings with the same mutation of COL4A4. The different phenotype of the same mutation may be explained by the involvement of chemical mediators or other structural proteins, such as the glomerular podocyte, which may interact with type IV collagen [6, 7] . Our patient's phenomena that he showed mild to nephrotic-range proteinuria only in various episodes of acute infection may suggest the involvement of chemical mediators such as cytokine or chemokine. Although it may remain possible that the patient has nephrotic syndrome associated with TBMN, we have evaluated that his unique clinical course could sufficiently reduce this possibility.
About 20 % of patients with TBMN show progressive renal impairment [8] . TBMN associated with heterozygous COL4A3/COL4A4 mutations was reported to show a causal relationship with the development of focal segmental glomerulosclerosis (FSGS) and renal failure [4, 9, 10] . TBMN itself may be a primary factor leading to chronic renal insufficiency and FSGS may be a consequence of proteinuria, though our patients had no sign of FSGS under light and electron microscopy at the time of biopsy.
In conclusion, this case highlights the unique phenotype of TBMN in an infant. Thinning of the GBM itself can cause transient nephrotic-range proteinuria, even in the early stages of TBMN. It is possible that the late development of chronic kidney insufficiency may be related to these episodes. Long-term observation is essential for patients with TBMN.
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